Skip to main content
Equibles

Sue Hohenleitner

CFO

Ardelyx, Inc. (ARDX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Ardelyx, Inc. publishes a filing, an earnings call transcript or a press release.

Get ARDX alerts

About Sue Hohenleitner

Sue Hohenleitner is recorded as CFO at Ardelyx, Inc. (ARDX). Ardelyx, Inc. reported in an 8-K filed October 14, 2025 that Sue Hohenleitner was appointed chief financial officer ("CFO") and principal financial officer, effective November 4, 2025. Sue Hohenleitner has spoken on 2 earnings calls and 2 other investor events across 1 company, most recently for Ardelyx, Inc. on November 3, 2026. Ardelyx, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ardelyx, Inc. includes Michael Raab (CEO and Board Member), Keith Santorelli (CFO), Susan Hohenleitner (CFO) and 7 others.

“On October 13, 2025, the board of directors (the "Board") of Ardelyx, Inc. (the "Company") appointed Sue Hohenleitner as chief financial officer ("CFO") and principal financial officer, effective November 4, 2025.”
Ardelyx, Inc. Form 8-K, filed October 14, 2025 · Read the filing

Sue Hohenleitner on recent calls

“Three points can stand out for me from our third quarter results. First, Israel continues to drive our growth with revenue up 23% year over year. Second, we're turning that growth into financial progress.”
CFO, Ardelyx to Report Third Quarter 2026 Financial Results on November 3, 2026 ·
“Yeah, I mean, the only thing I'd add is, you know, the guidance for the rest of the year doesn't reflect that any of those payer pressures are going to be eased off.”
CFO, Morgan Stanley 24th Annual Global Healthcare Conference ·
“So for those of you that don't know Aradelics, we are a company focused on developing and commercializing innovative products for unmet patient needs. So we have two currently commercialized products.”
CFO, Jefferies Global Healthcare Conference in New York ·
“As you heard from Mike and Eric, we are continuing to advance our commercial momentum to drive significant value creation. We are leveraging disciplined capital allocation into a clear strategic advantage by investing with purpose and commercial growth and building our pipeline.”
CFO, Ardelyx, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Ardelyx, Inc.

Recent activity